1Department of Molecular Biology, Massachusetts General Hospital, 50 Blossom Street, Boston, MA 02114, USA.
Researchers developed a novel peptide aptamer that selectively inhibits cyclin-dependent kinase 2 (Cdk2) activity. This engineered protein offers precise control over cellular processes, impacting cell cycle progression.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: